For studies involving complex interactions of multiple biomarkers, REALM Pharma Services offers multiplex immunofluorescence (mIF) assays, which can overcome the limitations of traditional immunohistochemistry. Our experts will work with you to develop a tailored approach, enabling you to identify targets of interest, investigate immune responses, isolate unique phenotypic signatures and validate your biomarkers for clinical use.
Our advanced pathology team leverages the Akoya PhenoCycler®-Fusion platform to quantify 34+ biomarkers on a single tissue slide, helping you get the most from your samples. We offer the PhenoCode™ Discovery Immune Profiling Human Protein Core panel, with add-ons to investigate tissue architecture, lymphocyte profiling and immune activation/proliferation.
Our in-house experts will work with you to customize off-the-shelf panels with a menu of readily available additional antibodies, or develop fully customized antibodies tailored to your specific biomarkers of interest.
Discover how REALM Pathology Services can help
accelerate your drug development.